Pharma News
Roche has just achieved a significant milestone with its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution receiving the CE Mark. This means the device is now approved for people over 18 with type 1 and type 2 diabetes who are on flexible insulin therapy. Matt Sause, CEO of Roche Diagnostics, highlighted the challenges faced by […]
Pharmacy Students Gear Up for Global Regulatory Challenges In a bid to navigate the intricate landscape of global pharmaceutical regulations, pharmacy students are increasingly focusing on qualification, training, and upskilling strategies. According to insights gathered by Pharmabiz from pharmacy students, the path to career advancement now hinges on mastering technology, regulations, and data analytics. These
First Case Under Bharatiya Nyaya Sanhita, 2023 Targets Illegal Drug Manufacturing in Telangana In a significant crackdown on counterfeit drug manufacturing, Telangana’s Pet Basheerabad Police Station has registered the first case under the Bharatiya Nyaya Sanhita, 2023 against an illegal drug manufacturer. The offender, operating clandestinely in Medchal-Malkajgiri district, was found producing counterfeit versions of
In response to recent closures affecting 36% of inspected drug manufacturing units nationwide due to non-compliance with Revised Schedule M standards, the Pondicherry Drug Manufacturers Association (PDMA) is set to host a seminar aimed at educating industry stakeholders on the updated Good Manufacturing Practices (GMP). Scheduled for July 13 in the union territory, the seminar
Roche has reported that the phase II/III SKYSCRAPER-06 study, investigating tiragolumab in combination with Tecentriq (atezolizumab) and chemotherapy as a first-line treatment for previously untreated, locally advanced unresectable or metastatic non-squamous non-small cell lung cancer, did not achieve its primary endpoints in its initial analysis. The study did not demonstrate statistically significant improvements in progression-free
Roche’s Tiragolumab Combination Falls Short in First-Line Lung Cancer Study Read More »
Budget 2024-25: Pharma, Healthcare Leaders Call for Strategic Investments and Policy Reforms As India gears up for the Union Budget 2024-25, leaders from the pharmaceutical and healthcare sectors are advocating for strategic investments, policy reforms, and incentives to bolster innovation and accessibility in healthcare. The Indian Pharmaceutical Alliance (IP Alliance), Metropolis Healthcare, Alyve Health, and
Pharma and Healthcare Leaders Urge Budget Focus on Innovation and Accessibility Read More »
Indian pharmaceutical companies regularly leverage events like the Indian Pharmaceutical Congress (IPC) to showcase their latest advancements in drug development, technology integration, and adherence to global quality standards. Industry leaders emphasize that IPC serves as a crucial platform for demonstrating India’s capabilities in innovation and its significant contributions to global healthcare through affordable medicines and
Researchers Use Mobile Phone Data to Track Pathogen Spread and Evolution In a groundbreaking study published in Nature, scientists have unveiled a novel approach to tracking the spread and evolution of pathogens like Streptococcus pneumoniae (pneumococcus), which are responsible for pneumonia, meningitis, and sepsis worldwide. This innovative method harnesses anonymised mobile phone data to map
Mobile Phone Data Unveils Pathogen Spread Insights, Raising New Vaccine Strategy Hopes Read More »
Medigene AG, a company specializing in immuno-oncology, has received a patent from the Chinese Patent Office for its T cell receptor (TCR) targeting NY-ESO-1 and LAGE 1a. These antigens are known to be associated with various types of solid tumors and have been extensively studied and validated. The patent protects Medigene’s innovative approach to developing
Indian Pharmaceutical Congress 73rd Edition Advocates Strengthening Pharma Education and Digital Innovation The ongoing Indian Pharmaceutical Congress (IPC) in Hyderabad has highlighted the critical need to bolster pharmaceutical education as a cornerstone for advancing manufacturing capabilities, pioneering R&D programs, and integrating digital technologies. At the forefront of discussions is the proposal to establish a Pharma
Telangana Proposes Pharma University at Indian Pharmaceutical Congress 73rd Edition Read More »
